Literature DB >> 6331674

Construction and applications of a highly transmissible murine retrovirus shuttle vector.

C L Cepko, B E Roberts, R C Mulligan.   

Abstract

We develop a murine retrovirus shuttle vector system for the efficient introduction of selectable and nonselectable DNA sequences into mammalian cells and recovery of the inserted sequences as molecular clones. Three protocols allow rapid recovery of vector DNA sequences from mammalian cells. Two of the methods rely on SV40 T-antigen-mediated replication of the vector sequences and yield thousands of bacterial transformants per 5 X 10(6) mammalian cells. The majority of plasmids recovered by all three protocols exhibited the proper structure and were as active as the parental vector in the generation of transmissible retrovirus genomes upon transfection of mammalian cells. One of the rescue methods, which relies on "onion skin" replication and excision of an integrated provirus from the host chromosome, enables facile recovery of the chromosomal site of proviral integration. The system was also used to generate, and then efficiently recover, a cDNA version of a genomic insert from the adenovirus E1A region.

Entities:  

Mesh:

Year:  1984        PMID: 6331674     DOI: 10.1016/0092-8674(84)90440-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  327 in total

1.  An olfactory sensory neuron line, odora, properly targets olfactory proteins and responds to odorants.

Authors:  J R Murrell; D D Hunter
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Biography of Constance L Cepko.

Authors:  Christen Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

5.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

6.  Novel retroviral vectors to facilitate expression screens in mammalian cells.

Authors:  Eugene Y Koh; Tong Chen; George Q Daley
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

7.  Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.

Authors:  A Mansukhani; P Dell'Era; D Moscatelli; S Kornbluth; H Hanafusa; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Authors:  G Kalinec; A J Nazarali; S Hermouet; N Xu; J S Gutkind
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

9.  Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily.

Authors:  L A Quilliam; S Zhong; K M Rabun; J W Carpenter; T L South; C J Der; S Campbell-Burk
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression.

Authors:  B E Roberts; J S Miller; D Kimelman; C L Cepko; I R Lemischka; R C Mulligan
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.